Cold case: COVID-19-triggered type 1 cryoglobulinemia von van Gils, L.A.J. (Luuk), Corsten, M.F. (Maarten), Koelman, C.A. (Carin), Bosma, R.J. (Renate), Fijnheer, R. (Rob), Mulder, A.H.L. (Leontine), Regelink, J.C. (Josien)

Volltext

Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission von de Laat, B, Traets, M J M, De Laat-Kremers, R W M, Verweij, S P, Ninivaggi, M, Jong, E, Huskens, D, Blok, B A, Remme, G C P, Miszta, A, Nijhuis, R H T, Herder, G J M, Fijnheer, R, Roest, M, Fiolet, A T L, Remijn, J A

Volltext

Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy stil... von Adams, H.J.A., Kwee, T.C., de Keizer, B., Fijnheer, R., de Klerk, J.M.H., Littooij, A.S., Nievelstein, R.A.J.

Volltext

Identification of N‐linked glycosylation and putative O‐fucosylation, C‐mannosylation sites in plasma derived ADAMTS13 von Sorvillo, N., Kaijen, P. H., Matsumoto, M., Fujimura, Y., Zwaan, C., Verbij, F. C., Pos, W., Fijnheer, R., Voorberg, J., Meijer, A. B.

Volltext

Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain von POS, Wouter, SORVILLO, Nicoletta, FIJNHEER, Rob, FEYS, Hendrik B, KAIJEN, Paul H. P, VIDARSSON, Gestur, VOORBERG, Jan

Volltext

Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura von Roose, Elien, Schelpe, An-Sofie, Tellier, Edwige, Sinkovits, György, Joly, Bérangère S., Dekimpe, Charlotte, Kaplanski, Gilles, Le Besnerais, Maelle, Mancini, Ilaria, Falter, Tanja, Von Auer, Charis, Feys, Hendrik B., Reti, Marienn, Rossmann, Heidi, Vandenbulcke, Aline, Pareyn, Inge, Voorberg, Jan, Greinacher, Andreas, Benhamou, Ygal, Deckmyn, Hans, Fijnheer, Rob, Prohászka, Zoltan, Peyvandi, Flora, Lämmle, Bernhard, Coppo, Paul, De Meyer, Simon F., Veyradier, Agnès, Vanhoorelbeke, Karen

Volltext

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome von HULSTEIN, J. J. J., VAN RUNNARD HEIMEL, P. J., FRANX, A., LENTING, P. J., BRUINSE, H. W., SILENCE, K., DE GROOT, PH. G., FIJNHEER, R.

Volltext

New therapeutic options for immune thrombocytopenia von SCHIPPERUS, M, FIJNHEER, R

Volltext

VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura von POS, W., LUKEN, B. M., KREMER HOVINGA, J. A., TURENHOUT, E. A. M., SCHEIFLINGER, F., DONG, J.‐F., FIJNHEER, R., VOORBERG, J.

Volltext

Agonist‐induced platelet reactivity correlates with bleeding in haemato‐oncological patients von Batman, B., Bladel, E. R., Hamersveld, M., Pasker‐de Jong, P. C. M., Korporaal, S. J. A., Urbanus, R. T., Roest, M., Boven, L. A., Fijnheer, R.

Volltext

Splenectomy for the treatment of thrombotic thrombocytopenic purpura von Kappers‐Klunne, M. C., Wijermans, P., Fijnheer, R., Croockewit, A. J., Holt, B., Wolf, J. T. M., Löwenberg, B., Brand, A.

Volltext

Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomi... von Minnema, M. C., Fijnheer, R., De Groot, P. G., Lokhorst, H. M.

Volltext

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL von Rijneveld, A., Gradowska, P., Bellido, M., Weerdt, O., Gadisseur, A., Deeren, D., Wagen, L., Jauw, Y., Fijnheer, R., Lammerren, D., Selleslag, D., Halkes, S., Biemond, B., Breems, D., Moors, I., Sluis, G., Bakkus, M., Homburg, C., Janda, V., Velden, V., Cornelissen, J.

Volltext

RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON‐NORDIC LYMPHOMA GROUP PHASE III STUDY von Lugtenburg, P., Nully Brown, P., Holt, B., d'Amore, F., Koene, H., Jongh, E., Fijnheer, R., Loosveld, O., Böhmer, L., Pruijt, H., Verhoef, G., Hoogendoorn, M., Bilgin, Y., Nijland, M., Lam, K., Keizer, B., Jong, D., Zijlstra, J.

Volltext

Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocy... von LUKEN, B. M., KAIJEN, P. H. P., TURENHOUT, E. A. M., KREMER HOVINGA, J. A., VAN MOURIK, J. A., FIJNHEER, R., VOORBERG, J.

Volltext

The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting von Ypma, P. F., Kerkhoffs, J.-L. H., van Hilten, J. A., Middelburg, R. A., Coccoris, M., Zwaginga, J. J., Beckers, E. M., Fijnheer, R., van der Meer, P. F., Brand, A.

Volltext

The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission von GROOT, E., FIJNHEER, R., SEBASTIAN, S. A. E., DE GROOT, PH. G., LENTING, P. J.

Volltext

FRETS‐VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura von GROOT, E., HULSTEIN, J. J. J., RISON, C. N., DE GROOT, P. G., FIJNHEER, R.

Volltext

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome von Frijns, C J M, Fijnheer, R, Algra, A, van Mourik, J A, van Gijn, J, Rinkel, G J E

Volltext

Risk factors for cystoid macular oedema in patients with uveitis von van Kooij, B, Probst, K, Fijnheer, R, Roest, M, de Loos, W, Rothova, A

Volltext